Navigation Links
TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
Date:8/21/2008

NEW YORK, MUNICH, Germany and AMSTERDAM, Netherlands, Aug. 21 /PRNewswire/ -- Paul Capital Healthcare and SpePharm Holding, B.V., the pan-European specialty pharmaceutical company, today announced that they have entered into a euro 10 million revenue interest acquisition financing agreement to fund SpePharm's acquisition of Dantrium(R) for Europe and certain other markets, from Procter & Gamble Pharmaceuticals. At the same time, TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare also announced the closing of a euro 16 million equity financing round to fund the ongoing growth of SpePharm Holding, B.V. SpePharm's senior management will also participate in this current equity financing.

Jean-Francois Labbe, Chief Executive Officer of SpePharm, said:

"We are very pleased and excited by this major step in the development of our company. The investment made by Paul Capital Healthcare and the increased financial commitment of our founding investors TVM Capital and Signet Healthcare Partners will enable SpePharm to accelerate the implementation of its strategy to become a leading pan-European specialty pharmaceutical company. These transactions will provide SpePharm with the resources to complete the build up of our sales and marketing infrastructure, launch and promote our current product portfolio and acquire rights to additional products in areas of therapeutic interest."

Mr. Labbe continued:

"Dantrium is a unique product used to treat malignant hyperthermia, a life-threatening reaction to certain gaseous anesthetics. Dantrium's significant clinical benefit fits perfectly with SpePharm's focus on hospital products that provide substantial medical and economic value. Procter & Gamble has established a solid commercial platform for Dantrium, and we believe that SpePharm has the strategy and resources to enhance the product's commercial and clinical value."

Dr. Ken Macleod, a partner at Paul Capital Healthcare, said
'/>"/>

SOURCE Paul Capital Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Quintiles Completes Previously Announced New Investor Partnership, Co-Led by Founder, Chairman and CEO Dennis Gillings, Bain Capital, TPG and 3i
2. Deloitte Agrees to Acquire Recombinant Capital, A Leading Life Sciences Subscription Database and Advisory Services Firm
3. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
4. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
7. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
8. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
9. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... PharmaBoardroom,s new report, , Healthcare and ... free download , digs deep into this vibrant market, ... sector today. One area where Algeria ... a homegrown pharmaceutical manufacturing base, even if the government,s ambitious ... off. A cursory comparison with neighboring Morocco ...
(Date:12/22/2014)... 22, 2014 The Center for ... of technical training across the life sciences industry, has ... (SCDM) to provide the organization's members with discounted ... access to the more than 350 sessions across 80 ... 10% off when registering for a public course ...
(Date:12/22/2014)... DIEGO , Dec. 22, 2014 GenomeDx ... the Decipher Prostate Cancer Classifier, a genomic test for ... in node-negative, high-risk men managed by radical prostatectomy without ... radical prostatectomy is relatively uncommon, using tumor genomics to ... of metastatic disease is an important advance. The study ...
(Date:12/22/2014)... Fertility Associates of Memphis has announced a ... a network of more than 20 contributing fertility ... fast access to a national pool of frozen ... Associates of Memphis is the only fertility clinic in ... Dr. William Kutteh , director of Fertility Associates ...
Breaking Biology Technology:PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3
... Alfacell Corporation,(Nasdaq: ACEL ) today announced that ... 29, 2008 notifying the Company that its,securities will ... June 25,2008, NASDAQ notified the Company that the ... the minimum $35 million required for continued,inclusion on ...
... FALLS, N.J., Aug. 1 CANTEL MEDICAL,CORP. (NYSE: ... Crosstex,International, Inc. subsidiary, effective today. As planned, Richard ... retired effective today,after over 50 years with Crosstex, ... Gary Steinberg and Mitchell Steinberg, also,former owners of ...
... and ... Diagnostic System, ... announced it has entered into a non-binding letter of,intent to ... real-time wireless beat-to-beat, intelligent heart monitor and,diagnostic system, designed for ...
Cached Biology Technology:Alfacell Receives NASDAQ Delisting Letter 2Alfacell Receives NASDAQ Delisting Letter 3Cantel Medical Announces Management Succession at Crosstex Healthcare Disposables Subsidiary 2Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 2Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 3Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 4Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 5
(Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research ... announced the addition of the "Global Facial ... http://photos.prnewswire.com/prnh/20130307/600769 ... the identification of individuals. Facial recognition system measures ... as nose, jaw edges, mouth, and the distance ...
(Date:12/11/2014)... PAUL, Minn. , Dec. 10, 2014 /PRNewswire/ ... wireless physiologic monitoring, has released a new series ... needs of preclinical toxicology researchers. M series, part ... help toxicologists collect the best possible physiologic data ... Adding functional endpoints to toxicology studies ...
(Date:12/10/2014)... SAN DIEGO , Dec. 9, 2014 ... and collaboration catalyst that provides the connective tissue that ... by enabling them to easily share client-level information; earned ... Foundation to expand to organizations serving seniors aging in ... San Diego" partner on December 11 th 4-6p. ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... disease typhoid fever results from the ongoing battle between the ... the body. Prof. Dirk Bumann,s research group at the Biozentrum ... typhoid pathogen repeatedly manages to evade the host,s immune system. ... Host & Microbe ". Typhoid fever is a bacterial ...
... natural gas pipelines have been found under the streets of ... Boston University. A dozen of the leaks could have ... concentrations as high as 500,000 parts per million of natural ... which explosions can occur. Four months after phoning ...
... from the University of Toronto (U of T) have found ... an individual,s nutritional needs vary by blood type--is not valid. ... . , "Based on the data of 1,455 ... diet theory," said the senior author of the study, Dr. ...
Cached Biology News:Typhoid fever -- A race against time 25,900 natural gas leaks discovered under Washington, D.C. 25,900 natural gas leaks discovered under Washington, D.C. 3Popular blood type diet debunked 2
Mouse monoclonal [34B12] to Nop5p + Nop58p - Nucleolar Marker ( Abpromise for all tested applications)....
... the ultimate tool for investigating dynamic events ... previously have been limited at wavelengths longer ... not transmit in the deep UV. HORIBA ... introduces a filter-based confocal system (the DynaMic) ...
... bind specifically to Fc regions of many ... conjugates are commonly used as affinity adsorbents ... from serum, hybridoma ascites fluids, tissue culture ... are also commonly used to capture immune ...
... This quick (10 min) assay can ... non-fluorescent substrate, 10-acetyl-3,7-dihydroxyphenoxazine (ADHP). H2O2 oxidizes ADHP ... fluorescent product resorufin (excitation at 530-571 nm, ... catalyzed by peroxidase in a one-step, homogeneous, ...
Biology Products: